Corbion and Kuehnle AgroSystems (KAS) have entered into a strategic partnership to develop algae-based astaxanthin derived from non-GMO heterotrophic algae for animal and human nutrition markets.
Corbion, an Amsterdam-based company specialising in sustainable ingredients, and US-based biotech company Kuehnle AgroSystems (KAS) have entered into a strategic partnership to develop and commercialize a high-quality, natural astaxanthin derived from non-GMO heterotrophic algae.
“This partnership reinforces our commitment to sustainable, science-based solutions,” said Robert Jan de Voogd, General Manager, Algae Ingredients North America at Corbion. “KAS’ technology offers a strong foundation to deliver high-quality natural astaxanthin to customers looking for a clean-label alternative.”
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms, including microalgae, salmon, and shrimp. It is widely recognized both for its human health benefits and as a key feed ingredient for salmon and other aquaculture species.
Currently, most commercially available astaxanthin is either chemically synthesized for aquaculture use or derived from the phototrophic microalgae Haematococcus for human health applications. Corbion and KAS aim to provide a natural, algae-derived alternative produced through controlled fermentation of non-GMO, heterotrophic Haematococcus, the primary natural source of astaxanthin.
“We’re proud to collaborate with Corbion to scale our technology and make premium algae-derived antioxidants more accessible worldwide” expressed Claude Kaplan, CEO of KAS.
The partnership will focus on developing an esterified form of astaxanthin, rich in the most bioavailable isomer, delivering superior antioxidant performance, enhanced stability, and fat solubility. Designed for both the human and animal nutrition markets, the companies highlight the product as being particularly well-suited for nutraceuticals and aquaculture applications.
By combining KAS’s advanced fermentation platform and proprietary non-GMO algae strains with Corbion’s industrial production capabilities, regulatory and go-to-market expertise, the two companies aim to bring this innovation to market at scale.
Development and technical transfer have already begun, with further updates to follow as the project progresses.
